Blueprint for the development of plant-derived vaccines for the poor in developing countries

TR Number




Journal Title

Journal ISSN

Volume Title



This Blueprint is the result of a series of international consultations and demonstrates that the development of plant-derived vaccines is both straightforward and achievable. A particular benefit of plant-derived vaccines is that their production could easily and economically be established in developing countries. The production in plants of large quantities of vaccines for oral administration is poised to revolutionize the world of vaccination and help bring to the poor the promise of existing and new vaccines for controlling infectious diseases. Due to economic and market realities, this promise will be achieved only through the collaboration of the public and private sectors with significant investments by both parties. These investments, however, will yield rich dividends in the form of widely available, inexpensive, orally administered, heat stable vaccines. The document specifically discusses pathways to produce vaccines against hepatitis B virus (HBV) and human papilloma virus (HPV) but also apply to other pathogens.


Metadata only record


Plants, Medical services, Disease control, Poverty, Health impacts, Health, Plant-derived vaccines, Infectious disease, Hepatitis b virus (hbv), Human papilloma virus (hpv), Governance


Prepared by PROVACS-Production of Vaccines from Applied Crop Sciences, A Program of The Center for Infectious Diseases and Vaccinology, The BioDesign Institute at Arizona State University, Tempe, Arizona